Blood Preparation Market Supply and demand, Technological breakthroughs by 2024

Blood components refer to products derived from platelet-rich plasma or whole blood. Blood components such as platelets, plasma, red blood cells, and white blood cells are derived from blood by the process of phlebotomy or hemapheresis through the technique of differential centrifugation. These blood components are separated from whole blood in hospital laboratories and blood centers, and are administered to patients suffering from various diseases through transfusion. The whole blood is often collected and separated into major components before transfusion. However, automated collections are becoming increasingly popular nowadays and only blood components that are needed for transfusion are collected.

Download Blood Preparation Market Sample PDF http://bit.ly/2aDRPr5

On the basis of product type, the global blood preparation market has been segmented into whole blood and blood components. While whole blood comprises platelets, plasma, red cells, and granulocytes, blood components constitute whole blood components, leukocyte reduced RBC, packed red cells, frozen plasma, and platelet concentrate. According to the antithrombotic and anticoagulant type, the blood preparation market has been divided into anticoagulants, fibrinolytics, and platelet aggregation inhibitors. Major application segments in the blood preparation market include renal impairment, thrombocytosis, and pulmonary embolism.

The growing demand for blood transfusion across emergency departments in hospitals has boosted the growth of the global blood preparation market. The rise in blood disorders such as thrombocytosis and the increasing requirement for blood during accidents and surgical procedures have supported the growth of the market.

According to the Centers for Disease Control and Prevention, conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) lead to over 60,000 deaths in the U.S. every year. Various initiatives taken by the National Institutes of Health and other regulatory bodies to spread awareness about the complications associated with these conditions have also propelled the market’s growth.

However, during blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high. This is the single major restraining factor impacting the growth of the global blood preparation market. The overall market has a significant opportunity to grow with the development of high speed technology to separate blood components without losing their activity. The introduction of new oral anticoagulants and the re-launch of drugs such as Urokinase, the growing demand for source plasma, and the need for specific blood components such as packed red blood cells will create new growth opportunities for the market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.